Research published in Natural Chemical Biology reveals that Wellington scientists have had success in developing a vaccine for asthma.
At this stage in the process, the vaccine has proven to prevent lung inflammation in mice. However, scientists will need about five more years of trials before the vaccine is able to be administered to humans. Still, this signals an exciting time for people who suffer from respiratory conditions. If this vaccine is approved, it could be a new, preventative method for dealing with allergies and other diseases, eliminating the need for respiratory inhalers or medications.
Program leader at the Malaghan Institute Franca Rochese explains, ""What we hope is that it's not like having to take drugs for your asthma, where you have to take them all the time."
Key Themes Behind This Trend
- Asthma Prevention
- The development of a vaccine for asthma could revolutionize the treatment and prevention of respiratory conditions.
- Disruptive Vaccines
- The success of the asthma vaccine research opens new possibilities for the development of vaccines for other diseases.
- Alternative to Inhalers
- The potential approval of the asthma vaccine could disrupt the respiratory medication industry by providing a preventative alternative to inhalers.
Where This Applies
- Pharmaceutical
- The development of innovative vaccines, such as the asthma vaccine, presents disruptive opportunities in the pharmaceutical industry.
- Healthcare
- The approval of the asthma vaccine would impact the healthcare industry by changing the approach to managing respiratory conditions.
- Medical Research
- The success in developing the asthma vaccine showcases the potential for disruptive innovations in medical research, specifically in disease prevention.
